Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy. [electronic resource]
Producer: 20121017Description: 941-6 p. digitalISSN:- 1432-1076
- Adrenergic beta-Antagonists -- therapeutic use
- Age Factors
- Biomarkers -- urine
- Case-Control Studies
- Drug Administration Schedule
- Female
- Hemangioma -- drug therapy
- Humans
- Infant
- Male
- Matrix Metalloproteinase 2 -- urine
- Matrix Metalloproteinase 9 -- urine
- Propranolol -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.